Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
134M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
7.51M
-
Shares change
-
-753K
-
Total reported value, excl. options
-
$52.5M
-
Value change
-
-$8.16M
-
Put/Call ratio
-
0.23
-
Number of buys
-
23
-
Number of sells
-
-24
-
Price
-
$6.99
Significant Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q3 2018
61 filings reported holding CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share as of Q3 2018.
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.51M shares
of 134M outstanding shares and own 5.62% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (2.61M shares), Vanguard Group Inc (1.19M shares), Rock Springs Capital Management LP (925K shares), Man Group plc (703K shares), NORGES BANK (644K shares), Quinn Opportunity Partners LLC (259K shares), Silphium Asset Management Ltd (203K shares), PEAK6 Investments LLC (99.3K shares), BANK OF AMERICA CORP /DE/ (87K shares), and TWO SIGMA INVESTMENTS, LP (86.4K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.